GSK - GSK Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GSK in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings or view top-rated stocks.

GSK's stock was trading at $44.10 at the start of the year. Since then, GSK stock has decreased by 23.4% and is now trading at $33.76.
View the best growth stocks for 2022 here.

GSK saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 11,250,000 shares, a decline of 15.8% from the October 31st total of 13,360,000 shares. Based on an average trading volume of 6,330,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 0.6% of the shares of the stock are sold short.
View GSK's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our GSK earnings forecast.

GSK plc (NYSE:GSK) issued its quarterly earnings results on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 EPS for the quarter, missing the consensus estimate of $0.64 by $0.02. The pharmaceutical company earned $8.74 billion during the quarter, compared to the consensus estimate of $8.71 billion. GSK had a net margin of 37.88% and a trailing twelve-month return on equity of 32.18%. The firm's quarterly revenue was down 1.8% on a year-over-year basis. During the same period last year, the company earned $0.39 earnings per share.
Read the conference call transcript.

GSK announced a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Friday, November 18th will be given a dividend of $0.3695 per share on Thursday, January 12th. This represents a $1.48 annualized dividend and a dividend yield of 4.38%. The ex-dividend date is Thursday, November 17th.
Read our dividend analysis for GSK.

GSK (NYSE:GSK) pays an annual dividend of $1.24 per share and currently has a dividend yield of 3.65%. The dividend payout ratio is 15.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GSK will have a dividend payout ratio of 36.47% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GSK.

GSK issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $50.67 billion-$51.60 billion, compared to the consensus revenue estimate of $32.29 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), Walt Disney (DIS) and NVIDIA (NVDA).

GSK trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

GSK's stock is owned by many different retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (0.60%), Price T Rowe Associates Inc. MD (0.55%), Renaissance Technologies LLC (0.46%), State Street Corp (0.37%), Two Sigma Investments LP (0.35%) and JTC Employer Solutions Trustee Ltd (0.23%).
View institutional ownership trends.

Shares of GSK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GSK stock can currently be purchased for approximately $33.76.

GSK (NYSE:GSK) has a market capitalization of $68.66 billion and generates $46.91 billion in revenue each year. The pharmaceutical company earns $6.03 billion in net income (profit) each year or $8.16 on an earnings per share basis.

The company employs 90,096 workers across the globe.

GSK's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The official website for the company is www.gsk.com. The pharmaceutical company can be reached via phone at 442080475000, via email at gsk.investor-relations@gsk.com, or via fax at 44-20-8047-7807.